CD30-targeted Oncolytic Viruses as Novel Therapeutic Approach Against Classical Hodgkin Lymphoma
Oncotarget - United States
doi 10.18632/oncotarget.24191
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 12, 2018
Authors
Publisher
Impact Journals, LLC